Bookmark and Share
BioAssay: AID 1674

Broad Institute MLPCN Ras Selective Lethality Project

Brent Stockwell, Columbia University, 614 Fairchild Center, MC 2406, 1212 Amesterdam Ave, New York, NY 10027, bs2189@columbia.edu, 212.854.2948 ..more
_
   
 Tested Compounds
 Tested Compounds
All(1)
 
 
Probe(1)
 
 
Active(1)
 
 
 Tested Substances
 Tested Substances
All(1)
 
 
Probe(1)
 
 
Active(1)
 
 
 Related BioAssays
 Related BioAssays
AID: 1674
Data Source: Broad Institute (2013)
BioAssay Type: Summary, Candidate Probes/Leads with Supporting Evidence
Depositor Category: NIH Molecular Libraries Probe Production Network
BioAssay Version:
Deposit Date: 2009-04-10
Modify Date: 2013-03-11

Data Table ( Complete ):           Active    All
BioActive Compound: Chemical Probe: 1    Active: 1
Depositor Specified Assays
Show more
AIDNameTypeComment
1554MLPCN Ras selective lethality-BJeLR viabilityscreening303344 hts compounds at singlepoint in BJeLR viability measuring activity set 1
1936Luminescence Cell-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to BJeLR RAS-Dependent Fibroblastconfirmatory1155 cherrypick compounds at dose in BJeLR viability measuring activity set 1
1933Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to BJ-TERT RAS-Independent Fibroblastconfirmatory1155 cherrypick compounds at dose in BJ-TERT viability measuring activity set 1
1935Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to BJ-TERT-LT-ST RAS-Independent Fibroblastconfirmatory1155 cherrypick compounds at dose in BJ-TERT-LT-ST viability measuring activity set 1
1934Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to DRD Non-Viral Oncogenic Fibroblastconfirmatory1155 cherrypick compounds at dose in DRD viability measuring activity set 1
2275Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cellsscreening30036 hts compounds at singlepoint in BJeLR viability measuring activity set 1
2607Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to Non-Viral Oncogenic DRD Fibroblasts.confirmatory14 drypowder compounds at dose in DRD AlamarBlue viability measuring activity set 1
2608Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJeLR Fibroblastsconfirmatory14 drypowder compounds at dose in BJeLR AlamarBlue viability measuring activity set 1
2609Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT-LT-ST Fibroblasts.confirmatory14 drypowder compounds at dose in BJ-TERT-LT-ST AlamarBlue viability measuring activity set 1
2610Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJeLR Fibroblastconfirmatory435 cherrypick compounds at dose in BJeLR AlamarBlue viability measuring activity set 1
2611Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT Fibroblasts.confirmatory14 drypowder compounds at dose in BJ-TERT AlamarBlue viability measuring activity set 1
2631Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT-LT-ST Fibroblastconfirmatory435 cherrypick compounds at dose in BJ-TERT-LT-ST AlamarBlue viability measuring activity set 1
2633Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to Non-Viral Oncogenic DRD Fibroblastconfirmatory73 cherrypick compounds at dose in DRD AlamarBlue viability measuring activity set 1
2635Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT Fibroblastconfirmatory73 cherrypick compounds at dose in BJ-TERT AlamarBlue viability measuring activity set 1
493045Primary viability screen, Ras selective lethality- BJeLR cells Measured in Cell-Based System Using Plate Reader - 2013-05_Inhibitor_Dose_DryPowder_Activityconfirmatory20 drypowder compounds at dose in BJeLR AlamarBlue viability measuring activity set 3
493054Viability counterscreen, Ras selective lethality- BJeH cells Measured in Cell-Based System Using Plate Reader - 2013-06_Inhibitor_Dose_DryPowder_Activityconfirmatory20 drypowder compounds at dose in BJ-TERT AlamarBlue viability measuring activity set 3
493052Viability counterscreen, Ras selective lethality- BJeHLT cells Measured in Cell-Based System Using Plate Reader - 2013-07_Inhibitor_Dose_DryPowder_Activityconfirmatory20 drypowder compounds at dose in BJ-TERT-LT-ST AlamarBlue viability measuring activity set 3
493051Viability counterscreen, Ras selective lethality- BJeH cells Measured in Cell-Based System Using Plate Reader - 2013-06_Inhibitor_Dose_DryPowder_Activity_Set2confirmatory31 drypowder compounds at dose in BJ-TERT AlamarBlue viability measuring activity set 2
493053Primary viability screen, Ras selective lethality- BJeLR cells Measured in Cell-Based System Using Plate Reader - 2013-05_Inhibitor_Dose_DryPowder_Activity_Set2confirmatoryPrimary viability screen, Ras selective lethality- BJeLR cells Measured in Cell-Based System Using Plate Reader set 2
493049Viability secondary screen, Ras selective lethality- DRD cells Measured in Cell-Based System Using Plate Reader - 2013-08_Inhibitor_Dose_DryPowder_Activityconfirmatory20 drypowder compounds at dose in DRD AlamarBlue viability measuring activity set 3
493050Viability secondary screen, Ras selective lethality- DRD cells Measured in Cell-Based System Using Plate Reader - 2013-08_Inhibitor_Dose_DryPowder_Activity_Set2confirmatory31 drypowder compounds at dose in DRD AlamarBlue viability measuring activity set 2
493093Viability counterscreen, Ras selective lethality- BJeHLT cells Measured in Cell-Based System Using Plate Reader - 2013-07_Inhibitor_Dose_DryPowder_Activity_Set2confirmatory31 drypowder compounds at dose in BJ-TERT-LT-ST AlamarBlue viability measuring activity set 2
652070HT29 HRAS Target ID Apoptosis Mulitlpe Timepoints Caspase 3/7 Measured in Cell-Based System Using Plate Reader - 2156-21_Inhibitor_Dose_DryPowder_ActivityconfirmatoryExtended probe characterization
652072LOX IMVI HRAS Target ID Apoptosis Mulitlpe Timepoints Caspase 3/7 Measured in Cell-Based System Using Plate Reader - 2156-22_Inhibitor_Dose_DryPowder_ActivityconfirmatoryExtended probe characterization
540314Viability counterscreen, Ras selective lethality- BJeHLT cells Measured in Cell-Based System Using Plate Reader - 2013-07_Inhibitor_Dose_DryPowder_Activity_Set4confirmatory
540315Viability secondary screen, Ras selective lethality- DRD cells Measured in Cell-Based System Using Plate Reader - 2013-08_Inhibitor_Dose_DryPowder_Activity_Set4confirmatory
540316Viability counterscreen, Ras selective lethality- BJeH cells Measured in Cell-Based System Using Plate Reader - 2013-06_Inhibitor_Dose_DryPowder_Activity_Set4confirmatory
540318Primary viability screen, Ras selective lethality- BJeLR cells Measured in Cell-Based System Using Plate Reader - 2013-05_Inhibitor_Dose_DryPowder_Activity_Set4confirmatory
Description:
Broad Institute of MIT and Harvard, Cambridge MA

NIH Molecular Libraries Probe Production Centers Network (MLPCN)
Grant Number MH084117-01

Internal Project ID: 2013

Keywords: Ras, apoptosis, cancer, VDAC, oxidative cell death

Primary Collaborators:

Brent Stockwell, Columbia University, 614 Fairchild Center, MC 2406, 1212 Amesterdam Ave, New York, NY 10027, bs2189@columbia.edu, 212.854.2948

Dan Zaharevitz, NCI Science Officer, zaharevd@mail.nih.gov

Project Overview:

The goal of the project is to identify small molecules in the MLSMR and related compound synthesized through follow-up chemistry that are selectively lethal to tumor cells expressing RAS oncogenes. These probes will not necessarily interact with the RAS pathway, but may induce cell death by affecting cellular processes that, in conjunction with the activation of the RAS pathway, selectively kill the tumor cells.

Primary Assay Summary:

Name: BJeLR viability

Internal ID: 2013-01

Cell viability of BJeLR (BJ fibroblasts transformed with hTERT, genomic SV40 LT and ST oncoproteins, and oncogenic HRASV12). Using CellTiterGlo, which measures the amount of intracellular ATP from living cells, the total amount of viable cells can be measured by luminescence readout. Cells are treated with compounds for 48 hours to allow detection of compounds that may be slower-acting.
Expected Outcome: Compounds that are toxic to these transformed fibroblasts, either selectively due to the HRAS oncogene or due to nonspecific toxicity, will cause a loss of luminescence signal due to fewer live cells. Specificity will be determined in future counterscreening.
Comment
The following compounds [SID] were purchased or synthesized for this project:
87692468 87692469 87692470 87692471 87692472 87692473 87692474 87692475 87692476 87692477 87692478 87692479 87692480 87692481
Result Definitions
TIDNameDescriptionHistogramTypeUnit
OutcomeThe BioAssay activity outcomeOutcome
ScoreThe BioAssay activity ranking scoreInteger
1ML_NUMML number assigned to compound.String
Additional Information
Grant Number: MH084117-01

Data Table (Concise)
PageFrom: